United Therapeutics | UTHR - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Amarin USD 443.62M 5.8M 2026-06
Ardelyx USD 148.62M 18.33M 2026-03
Baxter International USD 6.21B 163M 2026-06
Bayer EUR 29.71B 863M 2026-06
BioCryst Pharmaceuticals USD -454.29M 99.55M 2026-06
Biogen USD 18.85B 196.3M 2026-06
BioMarin Pharmaceutical USD 6.32B 109.58M 2026-06
Emergent BioSolutions USD 649.3M 47.9M 2023-12
Gilead Sciences USD 11.74B 11.77B 2026-06
GlaxoSmithKline GBP 17.64B 223M 2026-06
Halozyme Therapeutics USD 143.54M 76.09M 2026-06
Insmed USD 757.49M 52.64M 2026-06
Ionis Pharmaceuticals USD 439.74M 51.68M 2026-06
J&J USD 84.97B 3.78B 2026-06
Lexicon Pharmaceuticals USD 202.86M 95.32M 2026-03
Moderna USD 6.76B 647M 2026-06
Omeros USD -228.68M 15.13M 2025-06
Pfizer USD 85.19B 4.91B 2026-06
PTC Therapeutics USD -165.36M 15.1M 2026-06
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Sarepta Therapeutics USD 1.53B 22.7M 2026-06
Teva Pharmaceutical Industries USD 7.75B 475M 2026-06
United Therapeutics USD 6.4B 499.2M 2026-06
Vertex Pharmaceuticals USD 20.25B 886M 2026-06